By Dr. Shezad Malik, M.D., J.D. — Board‑Certified Physician & Product Liability Trial Attorney Dupixent® (dupilumab) is one of the most commonly prescribed biologic medications for eczema, asthma, and chronic sinus disease. But thousands of patients across the United States have reported a dangerous and unexpected complication: the development or acceleration of rare skin lymphomas, … Continue reading Dupixent Lymphoma Lawsuit Update (2026): Texas & Nationwide Claims for CTCL, Mycosis Fungoides, and Sézary Syndrome